Skip to main content
WA

www.actistent.com

The startup develops a cancer treatment technology that enhances the efficacy of palliative care for esophageal cancer through targeted research and clinical implementation of new therapeutic products. This approach enables healthcare professionals to provide more effective treatment options for patients with advanced disease stages.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • The startup develops a cancer treatment technology that enhances the efficacy of palliative care for esophageal cancer through targeted research and clinical implementation of new therapeutic products. This approach enables healthcare professionals to provide more effective treatment options for patients with advanced disease stages.
This profile is AI-generated and may contain inaccuracies.